News Snapshot:
A popular Chinese medical information site has been censored by authorities for "violation of relevant laws and regulations", months after its criticism of a government-backed herbal COVID-19 treatment sent shares in a pharmaceutical giant tumbling. DXY, which counts tech giant Tencent among its investors and runs a host of health-related services, previously questioned the value of Lianhua Qingwen, a herbal remedy marketed for fever and sore throats, as a COVID-19 treatment. China approved the concoction - made up of ingredients like honeysuckle and apricot seeds - as a COVID-19 treatment in 2020, and it was distributed to Shanghai residents during...
